American Society of Hematology

SHERPA: Blue

People

  1. Salles
    Salles
  2. Seshan
    Seshan
  3. Batlevi
    Batlevi
  4. Zelenetz
    Zelenetz
  5. Kumar
    Kumar
  6. Owens
    Owens
  7. Younes
    Younes
  8. Caron
    Caron
  9. Dogan
    Dogan
  10. Falchi
    Falchi

Groups

  1. Biostatistics Service (12)
  2. Center for Pancreatic Cancer Research (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Hematologic Malignancies, Division of (12)
  6. Center for Hematologic Malignancies (11)
  7. Lymphoma (11)
  8. Graduate Medical Education (7)
  9. GME, Medicine (6)
  10. Survivorship Research (6)
Search Within
  1. "Center for Pancreatic Cancer Research"
  2. "Gilles Salles"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (1)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (12)
  2. Center for Pancreatic Cancer Research (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Hematologic Malignancies, Division of (12)
  6. Center for Hematologic Malignancies (11)

More Groups

People
  1. Gilles Salles (12)
  2. Venkatraman Seshan (12)
  3. Andrew Zelenetz (7)
  4. Connie Batlevi (7)
  5. Ahmet Dogan (6)
  6. Anita Kumar (6)

More People

Years
  1. 2023 (5)
  2. 2022 (4)
  3. 2021 (1)
  4. 2020 (2)
Publications
  1. Blood (11)
  2. Blood Advances (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of sequential CD19-directed therapies in relapsed and refractory large B cell lymphoma
    Meeting Abstract

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M. H.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G.; Romancik, J. T.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genetic alterations of follicular lymphoma can predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular profiling across lymphoma subtypes using MSK-impact next generation sequencing
    Meeting Abstract

    Batlevi, C. L.; Drill, E.; Okwali, M.; Ptashkin, R.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • BCL6 rearranged indolent B-cell lymphomas show mutational profile similar to marginal zone lymphomas
    Meeting Abstract

    Galera, P. K.; Qualls, D.; Aypar, U.; Kostrzewa, C.; Zhu, M.; Baik, J.; Seshan, V.; Salles, G.; Dogan, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in relapsed/refractory large B cell lymphoma (R/R LBCL): Real world outcomes in a multicenter retrospective study
    Meeting Abstract

    Qualls, D.; Buege, M. J.; Dao, P.; Caimi, P. F.; Rutherford, S. C.; Wehmeyer, G.; Romancik, J. T.; Leslie, L. A.; Merrill, M. H.; Crombie, J. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
    Journal Article

    Qualls, D.; Lam, H. Y.; Whiting, K.; Kumar, A.; Matasar, M.; Owens, C.; Nichols, C.; Espeleta, J. A.; Qiu, A.; Subzwari, S.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save